Risk factors for hospital-acquired bloodstream infections caused by extended-spectrum β-lactamase Klebsiella pneumoniae among cancer patients

Irish Journal of Medical Science

Volumn 183, Issue 3, 2014, Pages 463-469

  Li, D ^a   Chen, Y ^a   Zhang, W ^a   Zheng, S ^a   Zhang, Q ^a   Bai, C ^a   Zhang, P ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Bloodstream infection; Cancer patient; ESBL; Klebsiella pneumoniae; Risk factor

Indexed keywords

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; CASE-CONTROL STUDIES; CEPHALOSPORINS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84904414320     PISSN: 00211265     EISSN: 18634362     Source Type: Journal    
DOI: 10.1007/s11845-013-1043-6     Document Type: Article

References (29)

1. Knothe H, Shah P, Krcmery V et al (1983) Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 11:315-317 (Pubitemid 14213754)
2. Villegas MV, Blanco MG, Sifuentes-Osornio J et al (2011) Increasing prevalence of extended-spectrum-β-lactamase among Gram-negative bacilli in Latin America - 2008 update from the study for monitoring antimicrobial resistance trends (SMART). Braz J Infect Dis 15:34-39
3. Hawser SP, Bouchillon SK, Hoban DJ et al (2009) Emergence of high levels of extended-spectrum-β-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the study for monitoring antimicrobial resistance trends (SMART) program, 2007. Antimicrob Agents Chemother 53:3280-3284. doi:10.1128/AAC.00426-09
4. Hawser SP, Bouchillon SK, Hoban DJ et al (2010) Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum β-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 study for monitoring antimicrobial resistance trends (SMART). Antimicrob Agents Chemother 54:3043-3046. doi:10.1128/aac.00265-10
5. Hoban DJ, Bouchillon SK, Hawser SP et al (2010) Susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in the US, 2007-2008: results of the study for monitoring antimicrobial resistance trends (SMART). Antimicrob Agents Chemother 54:3031-3034. doi:10.1128/aac.01808-09
6. Jung Y, Lee MJ, Sin HY et al (2012) Differences in characteristics between healthcare-associated and community-acquired infection in community-onset Klebsiella pneumoniae bloodstream infection in Korea. BMC Infect Dis 12:239. doi:10.1186/1471-2334-12-239
7. Wu HS, Wang FD, Tseng CP et al (2012) Characteristics of healthcare-associated and community-acquired Klebsiella pneumoniae bacteremia in Taiwan. J Infect 64:162-168. doi:10.1016/j.jinf.2011.11.005
8. Yinnon AM, Butnaru A, Raveh D et al (1996) Klebsiella bacteraemia: community versus nosocomial infection. QJM 89:933-941 (Pubitemid 27016323)
9. Paterson DL, Ko WC, Von Gottberg A et al (2004) Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum β-lactamases. Clin Infect Dis 39:31-37. doi:10.1086/420816 (Pubitemid 38879546)
10. Superti SV, Augusti G, Zavascki AP (2009) Risk factors for and mortality of extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and Escherichia coli nosocomial bloodstream infections. Rev Inst Med Trop Sao Paulo 51:211-216
11. Nasa P, Juneja D, Singh O et al (2012) An observational study on bloodstream extended-spectrum β-lactamase infection in critical care unit: incidence, risk factors and its impact on outcome. Eur J Intern Med 23:192-195. doi:10.1016/j.ejim.2011.06.016
12. Stewardson A, Fankhauser C, De Angelis G et al (2013) Burden of bloodstream infection caused by extended-spectrum β-lactamase-producing enterobacteriaceae determined using multistate modeling at a Swiss University hospital and a nationwide predictive model. Infect Control Hosp Epidemiol 34:133-143. doi:10.1086/669086
13. Webster DP, Young BC, Morton R et al (2011) Impact of a clonal outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in the development and evolution of bloodstream infections by K. pneumoniae and Escherichia coli: an 11 year experience in Oxfordshire. UK. J Antimicrob Chemother 66:2126-2135. doi:10.1093/jac/dkr246
14. Sanchez GV, Master RN, Clark RB et al (2013) Klebsiella pneumoniae antimicrobial drug resistance, US, 1998-2010. Emerg Infect Dis 19:133-136. doi:10.3201/eid1901.120310
15. Rosenthal VD, Bijie H, Maki DG et al (2012) International nosocomial infection control consortium (INICC) report, data summary of 36 countries, for 2004-2009. Am J Infect Control 40:396-407. doi:10.1016/j.ajic.2011.05.020
16. Chopra T, Marchaim D, Veltman J et al (2012) Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and Escherichia coli. Antimicrob Agents Chemother 56:3936-3942. doi:10.1128/aac. 05419-11
17. Quirante OF, Cerrato SG, Pardos SL (2011) Risk factors for bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Braz J Infect Dis 15:370-376
18. Passerini R, Ghezzi T, Sandri M et al (2011) Ten-year surveillance of nosocomial bloodstream infections: trends of aetiology and antimicrobial resistance in a comprehensive cancer centre. Ecancermedicalscience 5:p191. doi:10.3332/ecancer.2011.191
19. Clinical and Laboratory Standards Institute (2009) Performance standards for antimicrobial susceptibility testing; Nineteenth informational supplement. National Committee for Clinical Laboratory Standards, Wayne
20. Hussein K, Raz-Pasteur A, Finkelstein R et al (2013) Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae. J Hosp Infect 83:307-313. doi:10.1016/j.jhin.2012.10.012
21. Szilagyi E, Fuzi M, Borocz K et al (2009) Risk factors and outcomes for bloodstream infections with extended-spectrum β-lactamase-producing Klebsiella pneumoniae; Findings of the nosocomial surveillance system in Hungary. Acta Microbiol Immunol Hung 56:251-262. doi:10.1556/AMicr.56.2009.3.5
22. Silva N, Oliveira M, Bandeira AC et al (2006) Risk factors for infection by extended-spectrum β-lactamase producing Klebsiella pneumoniae in a tertiary hospital in Salvador, Brazil. Braz J Infect Dis 10:191-193 (Pubitemid 44463145)
23. Muro S, Garza-Gonzalez E, Camacho-Ortiz A et al (2012) Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis. Chemotherapy 58:217-224. doi:10.1159/000339483
24. Du B, Long Y, Liu H et al (2002) Extended-spectrum β-lactamase- producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Intensive Care Med 28:1718-1723. doi:10.1007/s00134-002-1521-1 (Pubitemid 35435472)
25. Fernandez-Canigia L, Dowzicky MJ (2012) Susceptibility of important Gram-negative pathogens to tigecycline and other antibiotics in Latin America between 2004 and 2010. Ann Clin Microbiol Antimicrob. 11:29. doi:10.1186/1476-0711-11-29
26. Serefhanoglu K, Turan H, Timurkaynak FE et al (2009) Bloodstream infections caused by ESBL-producing E. coli and K. pneumoniae: risk factors for multidrug-resistance. Braz J Infect Dis 13:403-407
27. Yu WL, Jones RN, Hollis RJ et al (2002) Molecular epidemiology of extended-spectrum β-lactamase-producing, fluoroquinolone-resistant isolates of Klebsiella pneumoniae in Taiwan. J Clin Microbiol 40:4666-4669 (Pubitemid 35434964)
28. Park SY, Kang CI, Joo EJ et al (2012) Risk factors for multidrug resistance in nosocomial bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Microb Drug Resist 18:518-524. doi:10.1089/mdr2012.0067
29. Oliveira AL, de Souza M, Carvalho-Dias VM et al (2007) Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients. Bone Marrow Transpl 39:775-781. doi:10.1038/sj.bmt.1705677 (Pubitemid 46901976)